Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients

BACKGROUND: We have previously shown bone marrow-derived mesenchymal stem cells (MSCs) may shift immune responses toward anti-inflammatory pathways and stabilize the course of obstructive chronic lung allograft syndrome (o-CLAD) after lung transplantation. In this study, we measured the response of...

Descripción completa

Detalles Bibliográficos
Autores principales: Erasmus, David Brett, Durand, Nisha, Alvarez, Francisco A, Narula, Tathagat, Hodge, David O, Zubair, Abba C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492292/
https://www.ncbi.nlm.nih.gov/pubmed/35881142
http://dx.doi.org/10.1093/stcltm/szac051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492292/
https://www.ncbi.nlm.nih.gov/pubmed/35881142
http://dx.doi.org/10.1093/stcltm/szac051

Ejemplares similares